Medtronic links renal denervation to 3-year blood pressure reduction

Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

Health systems are racing to adopt AI. But can they prove its value?

Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, like provider and patient satisfaction, are important too — and also impact providers’ bottom lines.

Corcym, CardioPrecision set sights on robotic heart valve replacement

The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.

J&J awards first grants from AI surgery fund

Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.

Ex-CEO of Magellan Diagnostics avoids prison over lead-test device defect

A Ticking Clock: How States Are Preparing for a Last-Minute Obamacare Deal

Behind the Dismantling of the C.D.C.: Reform or ‘Humiliation’?